B. Metzler seel. Sohn & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $269K | Hold |
4,889
| – | – | ﹤0.01% | 706 |
|
|
2025
Q1 | $346K | Hold |
4,889
| – | – | ﹤0.01% | 674 |
|
|
2024
Q4 | $321K | Hold |
4,889
| – | – | ﹤0.01% | 698 |
|
|
2024
Q3 | $344K | Sell |
4,889
-2,546
| -34% | -$179K | ﹤0.01% | 695 |
|
|
2024
Q2 | $612K | Buy |
7,435
+219
| +3% | +$18K | 0.01% | 612 |
|
|
2024
Q1 | $630K | Sell |
7,216
-2,300
| -24% | -$201K | 0.01% | 588 |
|
|
2023
Q4 | $918K | Hold |
9,516
| – | – | 0.01% | 517 |
|
|
2023
Q3 | $842K | Buy |
9,516
+1,430
| +18% | +$127K | 0.01% | 500 |
|
|
2023
Q2 | $701K | Sell |
8,086
-58,400
| -88% | -$5.06M | 0.01% | 538 |
|
|
2023
Q1 | $6.47M | Hold |
66,486
| – | – | 0.1% | 131 |
|
|
2022
Q4 | $6.88M | Sell |
66,486
-1,977
| -3% | -$205K | 0.12% | 120 |
|
|
2022
Q3 | $5.8M | Buy |
68,463
+58,464
| +585% | +$4.96M | 0.11% | 137 |
|
|
2022
Q2 | $828K | Buy |
9,999
+4,300
| +75% | +$356K | 0.01% | 481 |
|
|
2022
Q1 | $439K | Buy |
5,699
+362
| +7% | +$27.9K | 0.01% | 624 |
|
|
2021
Q4 | $475K | Sell |
5,337
-6,225
| -54% | -$554K | 0.01% | 565 |
|
|
2021
Q3 | $894K | Buy |
11,562
+2,581
| +29% | +$200K | 0.01% | 460 |
|
|
2021
Q2 | $749K | Buy |
8,981
+694
| +8% | +$57.9K | 0.01% | 487 |
|
|
2021
Q1 | $626K | Sell |
8,287
-17,100
| -67% | -$1.29M | 0.01% | 510 |
|
|
2020
Q4 | $2.21M | Buy |
+25,387
| New | +$2.21M | 0.04% | 252 |
|